Form 4 for BJDX Bluejay Diagnostics, Inc.

Accepted 2022-03-16 00:00:00 ET · period of report 2022-03-14 · accession 0001213900-22-013084 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-03-16	2022-03-14+	BJDX	Kinder Gordon Winston	CFO	P - Purchase	$0.9706	+16.0K	16.0K	New	+$15.5K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-14	P	A	10,500	$0.95	10,500	D	—	—	(F1) This transaction was executed in multiple trades at prices ranging from $0.90 to $0.95. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
2	Common	Common Stock	2022-03-15	P	A	500	$0.91	11,000	D	—	—
3	Common	Common Stock	2022-03-16	P	A	5,000	$1.02	16,000	D	—	—	(F2) This transaction was executed in multiple trades at prices ranging from $1.01 to $1.04. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.